Taken from Yahoo! Finance:
Description
"Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops opioid antagonist treatments for addictions and related disorders. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses.The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California. Opiant Pharmaceuticals, Inc. operates as a subsidiary of Pelikin Group."
Today, OPNT received approval to begin trading officially on the Nasdaq exchange. This comes from a previous listing on the OTC boards.
I have been watching this stock for several months. Opiant Pharma's newest drug was FDA approved only recently. Narcan is the only FDA approved and patented Nalaxone administered nasally. Opiant gives permission to Adapt Pharma located in Ireland to distribute and manufacture their drug.
Opiant is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa, an eating disorder; and heroin vaccine.
With the recent scourge of drug overdoses Narcan is set to take off worldwide. It is also one of the cheaper options for patients.
Police and fire departments receive special pricing as well as schools and other civic facilities.
Only recently has this stock popped since CEO of Opiant Roger Crystal appeared on a segment of Fox and Friends.
Stock went from $7 to its current high of $23.48 in less than 2 months.
I post this advice for any amateur trader who wants a great stock at a discount. This company is only trading at a P/E of about 8 whereas their patent for Narcan expires in about 17 years. It's an almost guaranteed stock.
Many people ask me daily for sure bets. Even though there is rarely a sure bet, this is the closest it will get to it.
Thank you.
TraderNathan
Submitted August 28, 2017 at 04:53PM by TraderNathan http://ift.tt/2iE3GKu
No comments:
Post a Comment